Experiment 69499

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismValeriana officinalis (VALERIANACEAE)
CitationCOXETER,PD: SCHLUTER,PJ: EASTWOOD,HL: NIKLES,CJ: GLASZIOU,PP:. (2003). VALERIAN DOES NOT APPEAR TO REDUCE SYMPTOMS FOR PATIENTS WITH CHRONIC INSOMNIA IN GENERAL PRACTICE USING A SERIES OF RANDOMISED N-OF-1 TRIALS.. 11(4)
Amount utilized
Compound isolated
Disease43% WITHDRAWAL RATE POSSIBLE CROSSOVER BIAS DUE TO CARRYOVER EFFECTS. IN A SERIES OF N-OF-1 TRIALS, THE EFFECTS OF VALERIAN WERE ASSESSED IN 42 PATIENTS. OF THE 24 EVALUABLE PATIENTS, 100% REPORTED NO EFFECT ON TOTAL SLEEP TIME AFTER 1 WEEK OF TREATMENT. THE TRAIL WAS A RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY.
Dose amount450.0 MG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractTYPE EXT NOT STATED
GenderGIVEN TO BOTH SEXES